本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tenax Therapeutics, Inc.

2.32
+0.470025.41%
盤後2.340.0200+0.86%19:59 EDT
成交量:1,444.55萬
成交額:3,253.64萬
市值:8,682.34萬
市盈率:-1.58
高:2.43
開:2.08
低:2.08
收:1.85
52周最高:19.40
52周最低:1.31
股本:3,742.39萬
流通股本:1,751.51萬
量比:1.81
換手率:82.47%
股息:- -
股息率:- -
每股收益(TTM):-1.4685
每股收益(LYR):-1.3412
淨資產收益率:-59.80%
總資產收益率:-37.70%
市淨率:0.76
市盈率(LYR):-1.73

資料載入中...

2024/03/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/28

重要事件披露

Form 8-K - Current report
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/20

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/20

重要事件披露

Form 8-K - Current report
2024/02/16

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

重要事件披露

Form 8-K - Current report
2024/02/08

重要事件披露

Form 8-K - Current report
2024/02/06

重要事件披露

Form 8-K - Current report
2024/02/06

SEC問詢函

Form CORRESP - Correspondence
2024/02/06

SEC問詢函

Form CORRESP - Correspondence
2024/02/02

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/02

SEC問詢函

Form CORRESP - Correspondence
2024/02/01

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/12

重要事件披露

Form 8-K - Current report
2024/01/06

重要事件披露

Form 8-K - Current report
2023/12/02

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933